A novel lactic acid bacterium having high viability under acidic conditions, and a pharmaceutical, food or drink, and feed, each containing the lactic acid bacterium are provided by Lactobacillus paracasei MCC 1375 strain, and a pharmaceutical, food or drink, and feed, each containing the strain.